Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

C R Bard Inc (NYSE:BCR)

235.16
Delayed Data
As of 4:01pm ET
 +2.81 / +1.21%
Today’s Change
169.09
Today|||52-Week Range
235.16
+24.13%
Year-to-Date
New Lifetime High Reached: C.R. Bard (BCR)
9:59am / TheStreet.com - Paid Partner Content
The 3 Worst Dividend Aristocrats for Income-Hungry Investors
Jun 22 / MotleyFool.com - Paid Partner Content
CR Bard (BCR) at 52-Week High on Strong Product Pipeline
9:02am / Zacks.com - Paid Partner Content
LabCorp Sees Balanced Growth; Covance Synergy on Track
Jun 21 / Zacks.com - Paid Partner Content
Strong And Under The Radar: C.R. Bard (BCR)
Jun 29 / TheStreet.com - Paid Partner Content
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Jun 20 / Zacks.com - Paid Partner Content
DENTSPLY Sirona Set to Acquire MIS Implants for $375M
Jun 28 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close232.35
Today’s open232.53
Day’s range232.17 - 235.16
Volume539,211
Average volume (3 months)475,076
Market cap$16.7B
Dividend yield0.44%
Data as of 4:01pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-52.93%
Earnings growth (this year)+11.81%
Earnings growth (next 5 years)+10.18%
Revenue growth (last year)+2.78%
P/E ratio158.8
Price/Sales4.18
Price/Book11.53

Competitors

 Today’s
change
Today’s
% change
EWEdwards Lifesciences...+2.82+2.91%
ZBHZimmer Biomet Holdin...+1.23+1.03%
DXCMDexCom Inc+0.33+0.42%
WSTWest Pharmaceutical ...+1.60+2.15%
Data as of 4:04pm ET, 06/30/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$2.47
Annual revenue (last year)$3.4B
Annual profit (last year)$133.5M
Net profit margin3.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Tim M. Ring
President, Chief Operating Officer &
Director
John H. Weiland
Corporate headquarters
Murray Hill, New Jersey

Forecasts

Partner Offers

Search for Jobs